Clinical Trials Arena October 10, 2023
As sponsors seek to minimize trial delays and get new therapies to market faster, we explore whether increased adoption of a more patient-centric approach could make a difference to timelines.
Clinical research has never been a quick process, nor should it be. A vast amount of data is required to validate the safety and efficacy of an experimental treatment. This is gathered over three or four separate trial phases, each one studying an increasing number of participants in order to limit risk, optimize dosing, and understand a drug’s longer-term effects.
This entire process can take the best part of a decade according to Biotechnology Innovation Organization, and research from the Tufts Center for the Study of Drug Development...